7.87
-0.30 (-3.67%)
| Previous Close | 8.17 |
| Open | 8.08 |
| Volume | 8,065,451 |
| Avg. Volume (3M) | 9,381,698 |
| Market Cap | 5,373,284,864 |
| Price / Earnings (Forward) | 8.30 |
| Price / Sales | 0.860 |
| Price / Book | 1.02 |
| 52 Weeks Range | |
| Earnings Date | 29 Apr 2026 |
| Profit Margin | 10.70% |
| Operating Margin (TTM) | 8.21% |
| Diluted EPS (TTM) | 1.04 |
| Quarterly Revenue Growth (YOY) | -5.90% |
| Quarterly Earnings Growth (YOY) | 6.80% |
| Total Debt/Equity (MRQ) | 67.34% |
| Current Ratio (MRQ) | 1.12 |
| Operating Cash Flow (TTM) | 808.50 M |
| Levered Free Cash Flow (TTM) | 751.08 M |
| Return on Assets (TTM) | 3.53% |
| Return on Equity (TTM) | 12.52% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Instruments & Supplies (US) | Mixed | Mixed |
| Medical Instruments & Supplies (Global) | Mixed | Bearish | |
| Stock | Avantor, Inc. | Bearish | Bearish |
AIStockmoo Score
| Analyst Consensus | -0.5 |
| Insider Activity | 5.0 |
| Price Volatility | 0.5 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | 2.0 |
| Average | 1.40 |
|
Avantor Inc provides products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company operates through two segments: Laboratory Solutions and Bioscience Production. It offers materials & consumables, equipment & instrumentation, and services & specialty procurement. Product groups include Equipment & Instrumentation, Services & Specialty Procurement, Proprietary Materials & Consumables, and Third-Party Materials & Consumables. Materials & consumables include high-purity chemicals and reagents, lab supplies, customized excipients, single-use assemblies, chromatography products, sample preparation kits, and fluid handling solutions. It operates in the Americas, Europe, and AMEA. |
|
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Investment Style | Small Value |
| % Held by Insiders | 1.35% |
| % Held by Institutions | 103.17% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| New Mountain Capital, L.L.C. | 31 Dec 2025 | 14,000,000 |
| 52 Weeks Range | ||
| Median | 8.50 (8.01%) | |
| Total | 1 Sell | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Barclays | 06 Mar 2026 | 8.50 (8.01%) | Sell | 8.17 |
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| BRELLIER LUDOVIC | 7.96 | - | 146,566 | 1,166,665 |
| DINGEMANS SIMON | 8.14 | - | 50,270 | 408,994 |
| LUCIER GREGORY T | 8.31 | - | 35,270 | 293,094 |
| MAKIN LOUISE | 8.31 | - | 25,270 | 209,994 |
| MASSARO JOSEPH R | 8.31 | - | 25,270 | 209,994 |
| MEHRA SANJEEV K | 8.31 | - | 25,270 | 209,994 |
| MURTHY MALA | 8.31 | - | 25,270 | 209,994 |
| SEVERINO MICHAEL | 8.31 | - | 25,270 | 209,994 |
| SUMME GREGORY L | 8.31 | - | 25,270 | 209,994 |
| Aggregate Net Quantity | 383,726 | |||
| Aggregate Net Value ($) | 3,128,715 | |||
| Aggregate Avg. Buy ($) | 8.25 | |||
| Aggregate Avg. Sell ($) | - | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| LUCIER GREGORY T | Director | 08 May 2026 | Buy (+) | 10,000 | 8.31 | 83,100 |
| SUMME GREGORY L | Director | 07 May 2026 | Acquired (+) | 25,270 | 8.31 | 209,994 |
| SEVERINO MICHAEL | Director | 07 May 2026 | Acquired (+) | 25,270 | 8.31 | 209,994 |
| MEHRA SANJEEV K | Director | 07 May 2026 | Acquired (+) | 25,270 | 8.31 | 209,994 |
| MASSARO JOSEPH R | Director | 07 May 2026 | Acquired (+) | 25,270 | 8.31 | 209,994 |
| MAKIN LOUISE | Director | 07 May 2026 | Acquired (+) | 25,270 | 8.31 | 209,994 |
| DINGEMANS SIMON | Director | 07 May 2026 | Acquired (+) | 25,270 | 8.31 | 209,994 |
| LUCIER GREGORY T | Director | 07 May 2026 | Acquired (+) | 25,270 | 8.31 | 209,994 |
| MURTHY MALA | Director | 07 May 2026 | Acquired (+) | 25,270 | 8.31 | 209,994 |
| BRELLIER LUDOVIC | Officer | 01 May 2026 | Acquired (+) | 146,566 | 7.96 | 1,166,665 |
| DINGEMANS SIMON | Director | 01 May 2026 | Buy (+) | 25,000 | 7.96 | 199,000 |
| Show more | ||||||
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |